Viewing Study NCT02273050


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-03-02 @ 4:54 PM
Study NCT ID: NCT02273050
Status: COMPLETED
Last Update Posted: 2018-02-05
First Post: 2014-10-22
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control
Sponsor: AstraZeneca
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: D1680C00009
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators